Pioglitazone News and Research

RSS

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

ChatGPT-4 to identify drug repurposing candidates against Alzheimer’s disease (AD).

28 Feb 2024

Revised guidelines for diabetes care

A recent Diabetes Care journal paper summarized the latest recommendations offered to people with diabetes to improve their health and well-being.

15 Dec 2022

Study allows people with type 2 diabetes to choose their own medication

A large-scale new study offers a new approach to treating type 2 diabetes - that puts patients in charge of their own medication. The Trimaster study is the first to allow people with type 2 diabetes to choose their own medication, after trying three different drugs in succession.

7 Dec 2022

Diabetes and the mTOR pathway in COVID-19 patients

A new study discusses the possible etiopathogenetic mechanisms associated with diabetes that could enhance the severity of COVID-19.

6 Mar 2022

Drug treatment decreases risk for severe COVID-19 outcomes in patients with Type 2 diabetes

A type of drug already used to treat obesity and Type 2 diabetes, when taken six months prior to the diagnosis of COVID-19, was associated with a decreased risk of hospitalization, respiratory complications and death in COVID-19 patients with Type 2 diabetes, according to researchers at Penn State College of Medicine.

27 Sep 2021

Researchers detect a novel cause of acquired lipodystrophy

Nonalcoholic fatty liver disease (NAFLD) is mostly diagnosed in overweight and obese people. However, severe forms of NAFLD can also be detected in rare genetic diseases such as lipodystrophy or in patients with HIV, putting them at a high risk for developing liver failure, diabetes and cardiovascular diseases.

3 Mar 2020

Diabetes drug abolishes characteristic signs of nicotine withdrawal in mice

A drug commonly used to treat Type II diabetes abolishes the characteristic signs of nicotine withdrawal in rats and mice, according to new research published in JNeurosci. The finding may offer an important new strategy in the battle to quit smoking.

From Society for Neuroscience 30 Oct 2019

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Like catching two fish with one worm, treating two problems with a single drug is efficient, but exceedingly difficult.

25 Sep 2019

UTHealth researchers investigate how to reduce stress-driven alcohol use

Researchers at The University of Texas Health Science Center at Houston (UTHealth) are investigating if a medication used to regulate blood sugar can alter motivation to use alcohol by targeting the brain's stress response system.

17 Jul 2019

UW-Madison researchers develop new method to track Parkinson's damage in the heart

A new way to examine stress and inflammation in the heart will help Parkinson's researchers test new therapies and explore an unappreciated way the disease puts people at risk of falls and hospitalization.

13 Jul 2018

Newer treatment for type 2 diabetes reduces liver fat in patients with NAFLD

In people with type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) is common and can progress to a severe liver disease known as nonalcoholic steatohepatitis (NASH).

19 Mar 2018

Experimental diabetes drugs can make cancer cells vulnerable to chemotherapy agents

Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy agents, and they say such combinations should be explored to potentially improve outcomes for cancer patients.

2 Jan 2018

Diabetes patients least likely to follow medical advice regarding medication due to side effects

Diabetes patients who take the most commonly prescribed diabetes drug, metformin, are the least likely to follow medical advice regarding their medication due its side effects, a new article in the journal Diabetes, Obesity and Metabolism reports.

18 Dec 2017

Researchers highlight need for paradigm shift in management of type 2 diabetes

Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance.

21 Jun 2017

Treating PCOS in adolescent girls may help prevent future subfertility, research suggests

In adolescent girls with polycystic ovary syndrome (PCOS), bringing the amount of abdominal visceral fat and liver fat down to normal restores ovulation, normalizes the symptoms of androgen excess, and may help prevent future subfertility, new research from Spain suggests.

4 Apr 2017

Pioglitazone News and Research

ChatGPT aids in discovering potential Alzheimer’s treatments through drug repurposing

Revised guidelines for diabetes care

Study allows people with type 2 diabetes to choose their own medication

Diabetes and the mTOR pathway in COVID-19 patients

Drug treatment decreases risk for severe COVID-19 outcomes in patients with Type 2 diabetes

Researchers detect a novel cause of acquired lipodystrophy

Diabetes drug abolishes characteristic signs of nicotine withdrawal in mice

Mystery underlying cardiac toxicity caused by diabetes drugs solved

UTHealth researchers investigate how to reduce stress-driven alcohol use

UW-Madison researchers develop new method to track Parkinson's damage in the heart

Newer treatment for type 2 diabetes reduces liver fat in patients with NAFLD

Experimental diabetes drugs can make cancer cells vulnerable to chemotherapy agents

Diabetes patients least likely to follow medical advice regarding medication due to side effects

Researchers highlight need for paradigm shift in management of type 2 diabetes

Treating PCOS in adolescent girls may help prevent future subfertility, research suggests

Type 2 diabetes drug may someday help combat breast and ovarian cancers

Targeted precision medicine can eliminate cancer risk in patients with Type 2 diabetes

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

Pioglitazone effective in diabetes patients with NASH

Clinical trial finds pioglitazone drug safe and effective for NASH patients

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News